Edgewise Therapeutics, Inc. (EWTX)
44.22
-0.50
(-1.12%)
USD |
NASDAQ |
Aug 25, 16:00
44.22
0.00 (0.00%)
After-Hours: 19:59
Edgewise Therapeutics Total Liabilities (Quarterly) : 31.61M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.61M |
| March 31, 2026 | 25.32M |
| December 31, 2025 | 30.35M |
| September 30, 2025 | 24.82M |
| June 30, 2025 | 24.26M |
| March 31, 2025 | 24.67M |
| December 31, 2024 | 27.60M |
| September 30, 2024 | 22.40M |
| June 30, 2024 | 21.17M |
| March 31, 2024 | 18.86M |
| December 31, 2023 | 21.20M |
| September 30, 2023 | 20.94M |
| Date | Value |
|---|---|
| June 30, 2023 | 19.17M |
| March 31, 2023 | 17.56M |
| December 31, 2022 | 20.38M |
| September 30, 2022 | 15.75M |
| June 30, 2022 | 11.04M |
| March 31, 2022 | 12.39M |
| December 31, 2021 | 10.85M |
| September 30, 2021 | 9.049M |
| June 30, 2021 | 6.739M |
| March 31, 2021 | 4.851M |
| December 31, 2020 | 164.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 479.69M |
| Shareholders Equity (Quarterly) | 448.08M |
| Debt to Equity Ratio | 0.008 |
| Current Ratio | 16.24 |
| Net Debt Paydown Yield | 0.00% |